EU market access Archives -

In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes

2021 market access prospects for France

https://pharmaphorum.com/views-analysis-market-access/2021-market-access-prospects-for-france/

2021 will be the year when big market access changes – including the far wider use of health

2021 market access prospects for Spain

https://pharmaphorum.com/views-analysis-market-access/2021-market-access-prospects-for-spain/

The market access landscape in Germany is particularly interesting in 2021, as a key component – AMNOG –

2021 market access prospects for Germany

https://pharmaphorum.com/views-analysis-market-access/2021-market-access-prospects-for-germany/

Italy was working up big changes in market access throughout 2020 which will be implemented in 2021. In

2021 market access prospects for Italy

https://pharmaphorum.com/views-analysis-market-access/2021-market-access-prospects-for-italy/

With the European Commission looking to formally strengthen health technology assessment (HTA) across Member States, Leela Barham attempts to

Resourcing HTA across Europe

https://pharmaphorum.com/views-analysis-market-access/resourcing-hta-across-europe/

EU market access